MCCLEAN, VA, UNITED STATES, December 16, 2024 /EINPresswire / -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveile ...
The device uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line ...
On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San ...
Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
On the morning of2, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK, 688331.SH) ...
Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two scientific abstracts with clinical data from the SPARKLE Phase ...
RemeGen’s Phase III trial of disitamab vedotin shows improved progression-free survival in advanced breast cancer patients ...
India Today on MSN4d
Worry about the genes you inherit, not property: Liver specialist Dr SK SarinHepatologist Dr SK Sarin, speaking at Agenda AajTak, urged people to look for inherited diseases and not wealth to assess a ...
Interim overall survival (OS) analyses at 31% maturity in patients with ESR1 mutations, and 23% maturity among all patients, ...
The trillions of microbial cells in our gastrointestinal tract have their own genomes and metabolic products, many of which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback